Bedtime antihypertensive dosing reduces nocturnal blood pressure across the general hypertensive population, but the magnitude of effect is modified by baseline non-dipper prevalence, with approximately two-fold higher nighttime SBP reductions in populations with higher proportions of non-dippers.
Key Findings
Results
Bedtime antihypertensive dosing significantly reduced nighttime systolic and diastolic blood pressure in the overall hypertensive population.
66 RCTs involving 29,654 participants were included in the meta-analysis.
Nighttime SBP was reduced by a weighted mean difference (WMD) of 4.87 mmHg (95% CI: 3.75–6.00).
Nighttime DBP was reduced by a WMD of 2.80 mmHg (95% CI: 2.23–3.37).
PubMed, EMBASE, and the Cochrane Library were searched; nighttime ambulatory SBP and DBP were primary outcomes.
Results
Bedtime dosing produced modest but measurable reductions in 24-hour and daytime blood pressure in the overall population.
24-hour SBP was reduced by a WMD of 2.06 mmHg.
Daytime SBP was reduced by a WMD of 0.99 mmHg.
These reductions were smaller in magnitude compared to the nighttime BP reductions.
Results
In trials restricted to non-dippers, bedtime dosing produced more pronounced reductions in nighttime blood pressure compared to the overall population.
Nighttime SBP WMD in non-dipper-restricted trials was 7.57 mmHg.
Nighttime DBP WMD in non-dipper-restricted trials was 3.77 mmHg.
These values were substantially larger than the overall population estimates of 4.87 mmHg (SBP) and 2.80 mmHg (DBP).
Results
Study populations with a higher baseline proportion of non-dippers (≥60%) experienced approximately two-fold greater nighttime SBP reductions compared to those with a lower prevalence (<60%).
Nighttime SBP WMD was approximately 9.7 mmHg in the ≥60% non-dipper group versus 4.4 mmHg in the <60% group (p < 0.01).
Nighttime DBP WMD was 5.1 mmHg versus 2.6 mmHg between the high and low non-dipper prevalence groups (between-group p < 0.05).
Subgroup analyses were pre-specified based on baseline non-dipper proportion using a threshold of 60%.
Conclusions
The chronotherapy effect of bedtime antihypertensive dosing is heterogeneous across trial populations rather than uniform, being modified at the study level by baseline non-dipper prevalence.
The meta-analysis included subgroup analyses based on baseline non-dipper proportion (<60% vs. ≥60%).
The authors conclude that 'chronotherapy effects are heterogeneous across trial populations rather than uniform across all hypertensive individuals.'
This finding suggests that the composition of the study population with respect to dipping status substantially influences observed treatment effects in bedtime dosing trials.
What This Means
This research conducted a large meta-analysis of 66 randomized controlled trials (involving nearly 30,000 participants) to examine whether taking blood pressure medications at bedtime, rather than in the morning, more effectively lowers nighttime blood pressure. Overall, bedtime dosing did reduce nighttime blood pressure meaningfully — by about 4.9 mmHg systolic and 2.8 mmHg diastolic on average — while producing only modest reductions in daytime or 24-hour blood pressure readings.
A key finding was that the benefit of bedtime dosing was not the same for everyone. People who are classified as 'non-dippers' — meaning their blood pressure does not drop normally during sleep — appeared to benefit much more from bedtime dosing. In studies where most participants were non-dippers (60% or more), the nighttime blood pressure reduction was roughly twice as large as in studies where fewer participants were non-dippers. This suggests that knowing a patient's blood pressure dipping pattern could help predict how much they would benefit from switching their medication timing.
This research suggests that the debate around bedtime versus morning antihypertensive dosing may have been complicated by the fact that different studies enrolled different types of patients. The benefit of bedtime dosing appears to be real but is concentrated in people who already have abnormal nighttime blood pressure patterns. Rather than recommending bedtime dosing universally, these findings point toward a more personalized approach where patients' nighttime blood pressure profiles are considered when deciding on medication timing.
Li M, Zhou Z, Fan F, Ma W, Li J, Zhang Y. (2026). Phenotype-Dependent Effect of Bedtime Antihypertensive Dosing on Nocturnal Blood Pressure: A Meta-Analysis Guided by Non-Dipper Prevalence.. Journal of clinical hypertension (Greenwich, Conn.). https://doi.org/10.1111/jch.70331